National Academies Press: OpenBook
« Previous: Appendix C: Statement of Task
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×
Page 75
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×
Page 76
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×
Page 77
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2014. Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18723.
×
Page 78

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

D Registered Attendees Nicholas Allen Khaled Bouri PXE International U.S. Food and Drug Administration Margaret Anderson FasterCures Henry Brem Johns Hopkins University Ronald Anson School of Medicine American College of Cardiology Ethan Brenna Genetic Alliance Daniel Arias Enetic Alliance Joel Brill Predictive Health, LLC Krishna Balakrishnan National Center for Eric Caplan Advancing Translational Biopractices, LLC Sciences Daniel Carlat Jeannie Baumann Pew Charitable Trusts Bloomberg BNA Ann Cashion Paul Billings National Institute of Life Technologies Nursing Research Corporation Guy Chisolm Julie Bolliner Cleveland Clinic Johns Hopkins University 75

76 COI AND MEDICAL INNOVATION Neal Cohen Kathi Huddleston University of California, Inova Translational San Francisco Medicine Institute Anthony Coyle David Innes Pfizer Inc. Mercer University Alyna Dada Rasika Kalamegham Genetic Alliance American Association for Cancer Research Rebecca English Institute of Medicine Francis Kalush U.S. Food and Drug Raith Erickson Administration Complete Genomics Steven Krosnick Stephanie Fischer National Institute of PhRMA Biomedical Imaging and Bioengineering, National J. Michael Fitzmaurice Institutes of Health Agency for Healthcare Research and Quality Katherine Lambertson Genetic Alliance Scott Fogerty Covance Gabriela Lavezzari PhRMA Daria Grayer Association of American Mark Lee Medical Colleges U.S. Food and Drug Administration Mary Grealy Healthcare Leadership Allen Lichter Council American Society of Clinical Oncology Rachel Hickey Genetic Alliance Bernard Lo Greenwall Foundation Jennifer Hobin American Association for Cancer Research

APPENDIX D 77 Savickis Mari Sally Rockey American Medical National Institutes of Health Association Allen Roses James Matthews Duke University Sanofi Pasteur Deborah Runkle Michelle McMurry-Heath American Association for U.S. Food and Drug the Advancement of Administration Science Kelly McVearry Kalyn Saulsberry Northrop Grumman Genetic Alliance Anne Michaels Michele Schoonmaker MNA, Inc. Cepheid Joseph Morgan Sal Shah Cleveland Clinic Shah Associates, LLC Neal Neuberger Shruti Sharma Health Tech Strategies Genetic Alliance Steve Olson Todd Sherer Institute of Medicine Emory University Consultant Ira Shoulson Charles Ornstein Georgetown University ProPublica Moushumi Sinha Heather Pierce Genetic Alliance Association of American Medical Colleges Mark Sobel American Society for Ronald Przygodzki Investigative Pathology U.S. Department of Veterans Affairs Rebecca Spence American Society of Clinical Oncology

78 COI AND MEDICAL INNOVATION Scott Steele University of Rochester Catherine Stevenson Genetic Alliance Sharon Terry Genetic Alliance Jill Hartzler Warner U.S. Food and Drug Administration Jennifer Weisman Strategic Analysis, Inc. Angele White Fair Chance, Inc. David Wierz OCI, LLC Erin Wilhelm Georgetown University Crispin Woolston Sanofi Rachel Zetts Pew Charitable Trusts Dorit Zuk National Institutes of Health

Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary Get This Book
×
 Conflict of Interest and Medical Innovation: Ensuring Integrity While Facilitating Innovation in Medical Research: Workshop Summary
Buy Paperback | $39.00 Buy Ebook | $31.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Scientific advances such as the sequencing of the human genome have created great promise for improving human health by providing a greater understanding of disease biology and enabling the development of new drugs, diagnostics, and preventive services. However, the translation of research advances into clinical applications has so far been slower than anticipated. This is due in part to the complexity of the underlying biology as well as the cost and time it takes to develop a product. Pharmaceutical companies are adapting their business models to this new reality for product development by placing increasing emphasis on leveraging alliances, joint development efforts, early-phase research partnerships, and public-private partnerships. These collaborative efforts make it possible to identify new drug targets, enhance the understanding of the underlying basis of disease, discover novel indications for the use of already approved products, and develop biomarkers for disease outcomes or directed drug use. While the potential benefits of collaboration are significant, the fact that the relationships among development partners are often financial means that it is vital to ensure trust by identifying, disclosing, and managing any potential sources of conflict that could create bias in the research being performed together.

Conflict of Interest and Medical Innovation is the summary of a workshop convened by the Institute of Medicine Roundtable on Translating Genomic-Based Research for Health in June 2013 to explore the appropriate balance between identifying and managing conflicts of interest and advancing medical innovation. A wide range of stakeholders, including government officials, pharmaceutical company representatives, academic administrators and researchers, health care providers, medical ethicists, patient advocates, and consumers, were invited to present their perspectives and participate in discussions during the workshop. This report focuses on current conflict of interest policies and their effect on medical innovation in an effort to identify best practices and potential solutions for facilitating innovation while still ensuring scientific integrity and public trust.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!